Company Encyclopedia
View More
name
VISHEE
688580.SH
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) for use in anxiety disorders, movement disorders, and ADHD applications; MagNeuro ONE, a TMS therapy system with navigation for use in anxiety disorders applications; and MagBelle, a pelvic floor muscle stimulator for use in urinary incontinence, pelvic organ prolapse, chronic pelvic pain, vaginal laxity, and bowel dysfunction applications. It also provides MagGraver, a powered muscle stimulator for use in abdominal sculpting and body sculpting applications; RFIntima, a radiofrequency therapy product for use in pelvic floor dysfunction, genitourinary syndrome of menopause, and vulvar atrophy applications; and PicoV, a Nd:YAG picosecond laser system for use in pigmentary diseases, and tattoo removal and skin reconstruction applications. In addition, the company offers solutions to pelvic floor and postpartum rehabilitation, rehabilitation medicine, psychiatry, pediatric rehabilitation, and aesthetic medicine.
890.25 B
688580.SHMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking43/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE7.70%B
    • Profit Margin29.03%A
    • Gross Margin68.27%A
  • Growth ScoreC
    • Revenue YoY2.75%C
    • Net Profit YoY11.71%C
    • Total Assets YoY2.68%C
    • Net Assets YoY2.83%C
  • Cash ScoreC
    • Cash Flow Margin344.44%C
    • OCF YoY2.75%C
  • Operating ScoreD
    • Turnover0.24D
  • Debt ScoreA
    • Gearing Ratio9.06%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Huafu Securities: The potential application scenarios downstream are extensive, and brain-computer interfaces are expected to welcome new opportunities

    Huafu Securities released a research report indicating that the brain-computer interface industry has formed a complete industrial chain, covering upstream materials, chips, midstream signal processing, and downstream medical and consumer fields. It is expected that the global market size will reach USD 2.62 billion in 2024 and will increase to USD 12.4 billion by 2034. China is in a leading position in non-invasive brain-computer interface technology, with widespread market demand, especially in medical rehabilitation and industrial intelligence, which is nurturing disruptive breakthroughs

    Zhitong·
    SZ
    300753
    +1.61%
    SH
    688580
    +1.91%
    SZ
    002819
    +2.38%
    Zhitong·
    SZ
    300753
    +1.61%
    SH
    688580
    +1.91%
    SZ
    002819
    +2.38%

    VISHEE released its performance for the first three quarters, with a net profit attributable to the parent company of 102 million yuan, a year-on-year increase of 30.68%

    According to the Zhitong Finance APP, VISHEE disclosed its third-quarter report for 2025. The company achieved revenue of 326 million yuan in the first three quarters, a year-on-year increase of 11.58%; the net profit attributable to shareholders of the listed company was 102 million yuan, a year-on-year increase of 30.68%; the net profit excluding non-recurring gains and losses was 93.6 million yuan, a year-on-year increase of 37.35%; basic earnings per share were 1.07 yuan

    Zhitong·
    SH
    688580
    +1.91%
    Zhitong·
    SH
    688580
    +1.91%

    VISHEE: In the first half of 2025, net profit reached 69.3242 million yuan, a year-on-year increase of 39.71%

    VISHEE announced that its operating revenue in the first half of 2025 is 210 million yuan, a year-on-year increase of 9.85%. Net profit is 69.3242 million yuan, a year-on-year increase of 39.71%

    Zhitong·
    SH
    688580
    +1.91%
    Zhitong·
    SH
    688580
    +1.91%

    The medical equipment sector has declined in the short term, with MEDLANDER falling over 7%

    The medical equipment sector has seen a short-term decline, with MEDLANDER falling over 7%. Xiangyu Medical, AOHUA ENDOSCOPY, Lude Medical, VISHEE, and others have also followed suit

    Zhitong·
    SH
    688580
    +1.91%
    SH
    688273
    +1.27%
    SH
    688626
    +1.03%
    Zhitong·
    SH
    688580
    +1.91%
    SH
    688273
    +1.27%
    SH
    688626
    +1.03%

    The concept of brain-computer interfaces has seen a surge, with Keeson hitting the daily limit up, followed by increases in VISHEE, Sanbo, CTN, Xiangyu Medical, and Innovative Medical

    Zhitong·
    SH
    688626
    +1.03%
    SZ
    002173
    +2.03%
    SH
    603610
    0.00%
    Zhitong·
    SH
    688626
    +1.03%
    SZ
    002173
    +2.03%
    SH
    603610
    0.00%
    © 2025 Longbridge｜Disclaimer